VA
TEVA icon

VestGen Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

VestGen Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$902K Sell
26,623
-3,871
-13% -$129K 0.03% 487
2026
Q1 		$1.09M Buy
30,494
+10,062
+49% +$324K 0.03% 433
2025
Q4 		$638K Buy
20,432
+2,717
+15% +$66.9K 0.03% 434
2025
Q3 		$358K Buy
+17,715
New +$311K 0.01% 557

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

VestGen Advisors's TEVA Position: Q2 2026 in Review

VestGen Advisors reduced its Teva Pharmaceuticals (TEVA) stake by 13% in Q2 2026, selling an estimated $129K and leaving 26,623 shares worth $902K. The position accounts for 0.03% of the portfolio, ranked #487.

VestGen Advisors first reported a position in TEVA in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.09M in Q1 2026. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • VestGen Advisors held 26,623 shares of Teva Pharmaceuticals worth $902K as of Q2 2026.
  • VestGen Advisors sold 3,871 Teva Pharmaceuticals shares in Q2 2026, an estimated $129K.
  • Teva Pharmaceuticals made up 0.03% of VestGen Advisors's portfolio in Q2 2026, its #487 holding.
  • VestGen Advisors first reported a position in Teva Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • VestGen Advisors's Teva Pharmaceuticals position peaked at $1.09M in Q1 2026.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on VestGen Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.